Guest Host: Steve Roberts

Vioxx, antidepressants, and a new FDA drug safety board are all on the agenda as Steve Roberts leads a discussion about the Food and Drug Administration and how well it is protecting consumers.


  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows

AT&T’s Proposed Acquisition Of Time Warner

Tuesday, Oct 25 2016AT&T’s bid to acquire Time Warner: Join us to talk about what the proposed merger of the country’s second-largest wireless carrier and a major content company could mean for consumers and the future of U.S. media and telecommunications.

The State Of The Presidential Race

Monday, Oct 24 2016Early voting is underway in states across the country. Just over two weeks before the presidential election, a look at the latest polls, the electoral map and end-of-the-line strategies for both campaigns.